Canada markets close in 2 hours 34 minutes

Consun Pharmaceutical Group Limited (C1P.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.5850+0.0050 (+0.86%)
As of 08:05AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 578.50M
Enterprise Value 182.74M
Trailing P/E 4.59
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.39
Price/Book (mrq)1.01
Enterprise Value/Revenue 0.07
Enterprise Value/EBITDA 0.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 30.87%
S&P500 52-Week Change 322.43%
52 Week High 30.7600
52 Week Low 30.5000
50-Day Moving Average 30.6377
200-Day Moving Average 30.5812

Share Statistics

Avg Vol (3 month) 3910
Avg Vol (10 day) 3100
Shares Outstanding 5811.02M
Implied Shares Outstanding 6997.41M
Float 8324.54M
% Held by Insiders 157.28%
% Held by Institutions 16.42%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.05
Forward Annual Dividend Yield 49.20%
Trailing Annual Dividend Rate 30.41
Trailing Annual Dividend Yield 370.34%
5 Year Average Dividend Yield 46.79
Payout Ratio 442.54%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 11, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 30.29%
Operating Margin (ttm)31.69%

Management Effectiveness

Return on Assets (ttm)9.93%
Return on Equity (ttm)21.38%

Income Statement

Revenue (ttm)2.59B
Revenue Per Share (ttm)3.28
Quarterly Revenue Growth (yoy)9.20%
Gross Profit (ttm)N/A
EBITDA 897.51M
Net Income Avi to Common (ttm)784.53M
Diluted EPS (ttm)0.1300
Quarterly Earnings Growth (yoy)13.10%

Balance Sheet

Total Cash (mrq)3.58B
Total Cash Per Share (mrq)4.52
Total Debt (mrq)511.53M
Total Debt/Equity (mrq)13.05%
Current Ratio (mrq)2.86
Book Value Per Share (mrq)4.58

Cash Flow Statement

Operating Cash Flow (ttm)818.97M
Levered Free Cash Flow (ttm)507.99M